The partnership further strengthens Tech Mahindra's Gen AI Medical Writing offering for Life Sciences by integrating Kitsa's KScribe platform, enabling pharmaceutical sponsors and CROs to accelerate ...
Clinical trial protocols lay the foundation for R&D, but they aren’t enough to ensure success. People, processes, and ...
Novartis has joined the likes of Eli Lilly and others by investing in the AI technology developer Yseop as part of a push to automate elements of clinical trial report writing that could speed drug ...
The integration of real-world data (RWD) into protocol feasibility and site selection has emerged as a clinical trial game-changer in recent years. Traditionally relying heavily on data from carefully ...
Hosted on MSN
Protocol flexibility and navigating the US geopolitical landscape in oncology clinical trials
Industry experts have provided insight into how oncology clinical trials can be designed for success from the outset and rendered as patient-centric as possible. At the Clinical Trials in Oncology ...
In the second of a two-part article, Gabrielle Faure-André and Stéphanie Garçon at Santarelli unpick EPO, UPC and French case law to assess the importance of clinical development timelines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results